Investigational RSV/hMPV vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigational RSV/hMPV vaccine, covering 2025-11-20 to 2025-11-20. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years [Phase 1]